View:
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 27, 1998 REGISTRATION NO. 333-57119 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________ POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _______________ INCYTE PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 94-3136539 (State or other jurisdiction of incorporation or organization) (I.R.S.Employer Identification No.) 3174 Porter Drive Palo Alto, California 94304 (650) 855-0555 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) ROY A. WHITFIELD Chief Executive Officer Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, California 94304 (650) 855-0555 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: STANTON D. WONG SALLY BRAMMELL Pillsbury Madison & Sutro LLP P.O. Box 7880 San Francisco, California 94120 _______________TERMINATION OF REGISTRATION Incyte Pharmaceuticals, Inc. (the "Registrant") hereby removes and withdraws from registration 922,987 shares of Common Stock, $.001 par value, of the Registrant. The Shares were unsold at the termination of the offering covered by this Registration Statement. SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Post-Effective Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Palo Alto, State of California, on October 27, 1998. INCYTE PHARMACEUTICALS, INC. By /s/ Denise M. Gilbert --------------------- Denise M. Gilbert Executive Vice President and CFO Pursuant to the requirements of the Securities Act, this Post-Effective Amendment No. 1 to the Registration Statement has been signed below by the following persons in the capacities and on the dates indicated. * By: /s/ Denise M. Gilbert ------------------------ Denise M. Gilbert Attorney-in-Fact
Name Title Date - - --------------------- ------------------------------- ---------------- Chief Executive Officer October 27, 1998 * (Principal Executive Officer) - - --------------------- and Director Roy A. Whitfield Executive Vice President and October 27, 1998 * Chief Financial Officer - - --------------------- (Principal Financial Officer) Denise M. Gilbert Controller * (Principal Accounting Officer) October 27, 1998 - - --------------------- William Delaney * Chairman of the Board October 27, 1998 - - --------------------- Jeffrey J. Collinson * Director October 27, 1998 - - --------------------- Barry M. Bloom October 27, 1998 * Director - - --------------------- Frederick B. Craves October 27, 1998 * Director - - --------------------- Jon S. Saxe October 27, 1998 * Director - - --------------------- Randal W. Scott